English

COR THERAPEUTICS INC / DE

EDGAR

Quarterly report (10-Q) · filed 2001-10-31

24 filing records in this dataset, filed from 1996-05-14 to 2001-10-31. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.89 million USD

1996-12-31 · USD

Exact inputs and evidence

Revenue: 18755000 USD Source
Revenue: 13867000 USD Source

Operating margin

-214.24%

1996-12-31 · %

Exact inputs and evidence

Operating Income: -39339000 USD Source
Operating Income: -28867000 USD Source
Revenue: 18755000 USD Source
Revenue: 13867000 USD Source

Operating cash flow

-7.57 million USD

1996-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -32850000 USD Source
Operating Cash Flow: -25277000 USD Source

Free cash flow

-7.94 million USD

1996-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -32850000 USD Source
Operating Cash Flow: -25277000 USD Source
Capital Expenditure: 2563000 USD Source
Capital Expenditure: 2199000 USD Source

Cash and cash equivalents: 243 million USD 2001-09-30 Source
Exact value

242835000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

2.23 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Net income: -16651000 USD · 2000-01-01 – 2000-12-31 Source
Net income: -17659000 USD · 2000-01-01 – 2000-09-30 Source
Net income: -2855000 USD · 2001-01-01 – 2001-03-31 Source
Net income: 3307000 USD · 2001-04-01 – 2001-06-30 Source
Net income: 771000 USD · 2001-07-01 – 2001-09-30 Source

Operating cash flow

-4.68 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Operating cash flow: -20077000 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -16755000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -2459000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -7066000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -2459000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -1355000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -7066000 USD · 2001-01-01 – 2001-06-30 Source

Capital expenditure

4.31 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Capital expenditure: 1176000 USD · 2000-01-01 – 2000-12-31 Source
Capital expenditure: 859000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 763000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 1471000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 763000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 3989000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 1471000 USD · 2001-01-01 – 2001-06-30 Source

Free cash flow

-8.98 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Operating cash flow: -20077000 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -16755000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -2459000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -7066000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -2459000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -1355000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -7066000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 1176000 USD · 2000-01-01 – 2000-12-31 Source
Capital expenditure: 859000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 763000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 1471000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 763000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 3989000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 1471000 USD · 2001-01-01 – 2001-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-10-31.

Financial data available through: 2000-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 1997-12-31
Operating income: 7 of 11 periods available· newest 2000-12-31
Net income: 7 of 11 periods available· newest 2000-12-31
Operating cash flow: 6 of 11 periods available· newest 2000-12-31
Capital expenditure: 7 of 11 periods available· newest 2000-12-31
Total assets: 7 of 11 periods available· newest 2000-12-31
Total liabilities: 6 of 11 periods available· newest 1999-12-31
Current assets: 6 of 11 periods available· newest 2000-12-31
Current liabilities: 6 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 9.42 million

Prior period

−USD 26.07 million

1999-01-01 – 1999-12-31
Current period

−USD 16.65 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-16651000 − -26070000 = 9419000 USD

-26070000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-16651000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · COR THERAPEUTICS INC / DE · 2000-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Year-over-year change in Net income: 9419000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -16651000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2012 Input fundies:NetIncome: -26070000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2012
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 13.95 million

Prior period

−USD 34.03 million

1999-01-01 – 1999-12-31
Current period

−USD 20.08 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-20077000 − -34031000 = 13954000 USD

-34031000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-20077000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · COR THERAPEUTICS INC / DE · 2000-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Year-over-year change in Operating cash flow: 13954000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -20077000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030 Input fundies:OperatingCashFlow: -34031000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-23.5%

Prior period

USD 1.54 million

1999-01-01 – 1999-12-31
Current period

USD 1.18 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

1176000 − 1538000 = -362000 USD

1538000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
1176000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · COR THERAPEUTICS INC / DE · 2000-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Year-over-year change in Capital expenditure: -362000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1176000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036 Input fundies:CapitalExpenditure: 1538000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1997 1997-01-01 – 1997-12-31

Revenue USD 22.19 million 100% of revenue
Operating costs Derived USD 57.9 million 261% of revenue
Operating income −USD 35.71 million −161% of revenue
Tax, interest and other Derived −USD 2.22 million −10% of revenue
Net income −USD 33.49 million −151% of revenue

Cash

Operating cash flow −USD 29.06 million −131% of revenue
Capital expenditure USD 1.91 million 8.6% of revenue
Free cash flow Derived −USD 30.97 million −140% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 8,577% of revenue.
1995 Operating loss: operating costs were 136% of revenue.
1996 Operating loss: operating costs were 310% of revenue.
1997 Operating loss: operating costs were 261% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	522000	44774000 Derived	-44252000	-4715000 Derived	-39537000	Unavailable	Source 1994-01-01 – 1994-12-31: 522000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -44252000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -39537000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: 4740000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	31850000	43421000 Derived	-11571000	-4040000 Derived	-7531000	-12850000 Derived	Source 1995-01-01 – 1995-12-31: 31850000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -11571000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -7531000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -10142000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 2708000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	18755000	58094000 Derived	-39339000	-2793000 Derived	-36546000	-35413000 Derived	Source 1996-01-01 – 1996-12-31: 18755000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -39339000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -36546000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -32850000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 2563000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	22190000	57898000 Derived	-35708000	-2216000 Derived	-33492000	-30968000 Derived	Source 1997-01-01 – 1997-12-31: 22190000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -35708000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -33492000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -29062000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 1906000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 22.2M 1997

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	522000	Revenue: 522000 Open source
19951995-12-31	Revenue	31850000	Revenue: 31850000 Open source
19961996-12-31	Revenue	18755000	Revenue: 18755000 Open source
19971997-12-31	Revenue	22190000	Revenue: 22190000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

18.3% 1997

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 522000 Open source
19951995-12-31	Year over year	6,001.5%	Revenue: 31850000 Open source Revenue: 522000 Open source
19961996-12-31	Year over year	-41.1%	Revenue: 18755000 Open source Revenue: 31850000 Open source
19971997-12-31	Year over year	18.3%	Revenue: 22190000 Open source Revenue: 18755000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -160.9% 1997

Net margin -150.9% 1997

Free cash flow margin -139.6% 1997

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	-8,477.4%	Operating Income: -44252000 Open source Revenue: 522000 Open source
19951995-12-31	Operating margin	-36.3%	Operating Income: -11571000 Open source Revenue: 31850000 Open source
19961996-12-31	Operating margin	-209.8%	Operating Income: -39339000 Open source Revenue: 18755000 Open source
19971997-12-31	Operating margin	-160.9%	Operating Income: -35708000 Open source Revenue: 22190000 Open source
19941994-12-31	Net margin	-7,574.1%	Net Income: -39537000 Open source Revenue: 522000 Open source
19951995-12-31	Net margin	-23.6%	Net Income: -7531000 Open source Revenue: 31850000 Open source
19961996-12-31	Net margin	-194.9%	Net Income: -36546000 Open source Revenue: 18755000 Open source
19971997-12-31	Net margin	-150.9%	Net Income: -33492000 Open source Revenue: 22190000 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 522000 Open source Capital Expenditure: 4740000 Open source
19951995-12-31	Free cash flow margin	-40.3%	Revenue: 31850000 Open source Operating Cash Flow: -10142000 Open source Capital Expenditure: 2708000 Open source
19961996-12-31	Free cash flow margin	-188.8%	Revenue: 18755000 Open source Operating Cash Flow: -32850000 Open source Capital Expenditure: 2563000 Open source
19971997-12-31	Free cash flow margin	-139.6%	Revenue: 22190000 Open source Operating Cash Flow: -29062000 Open source Capital Expenditure: 1906000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -29.1M 1997

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	Not reported	No source recorded
19951995-12-31	Operating cash flow	-10142000	Operating Cash Flow: -10142000 Open source
19961996-12-31	Operating cash flow	-32850000	Operating Cash Flow: -32850000 Open source
19971997-12-31	Operating cash flow	-29062000	Operating Cash Flow: -29062000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -31M 1997

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	Unavailable	Capital Expenditure: 4740000 Open source
19951995-12-31	Free cash flow	-12850000	Operating Cash Flow: -10142000 Open source Capital Expenditure: 2708000 Open source
19961996-12-31	Free cash flow	-35413000	Operating Cash Flow: -32850000 Open source Capital Expenditure: 2563000 Open source
19971997-12-31	Free cash flow	-30968000	Operating Cash Flow: -29062000 Open source Capital Expenditure: 1906000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

17.8% 1997

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Liabilities / assets	18.5%	Total Liabilities: 19636000 Open source Total Assets: 106367000 Open source
19951995-12-31	Liabilities / assets	18.5%	Total Liabilities: 18669000 Open source Total Assets: 100906000 Open source
19961996-12-31	Liabilities / assets	29.2%	Total Liabilities: 20803000 Open source Total Assets: 71245000 Open source
19971997-12-31	Liabilities / assets	17.8%	Total Liabilities: 16987000 Open source Total Assets: 95385000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.35× 1997

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	6.59×	Current Assets: 92829000 Open source Current Liabilities: 14095000 Open source
19961996-12-31	Current assets / current liabilities	3.68×	Current Assets: 64198000 Open source Current Liabilities: 17438000 Open source
19971997-12-31	Current assets / current liabilities	6.35×	Current Assets: 89977000 Open source Current Liabilities: 14170000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 39.54 million Exact value Exact value: -39537000 USD 1994-01-01 – 1994-12-31: -39537000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COR THERAPEUTICS INC / DE · 1994-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Net Income: -39537000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39537000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-97-001492.txt#2663 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 4.74 million Exact value Exact value: 4740000 USD 1994-01-01 – 1994-12-31: 4740000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COR THERAPEUTICS INC / DE · 1994-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Capital Expenditure: 4740000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4740000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-97-001492.txt#2688 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 7.53 million Exact value Exact value: -7531000 USD 1995-01-01 – 1995-12-31: -7531000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COR THERAPEUTICS INC / DE · 1995-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Net Income: -7531000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7531000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-98-001234.txt#2813 The citation records this snapshot. The page link may show a newer release later.	−USD 10.14 million Exact value Exact value: -10142000 USD 1995-01-01 – 1995-12-31: -10142000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COR THERAPEUTICS INC / DE · 1995-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Operating Cash Flow: -10142000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10142000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-98-001234.txt#2830 The citation records this snapshot. The page link may show a newer release later.	USD 2.71 million Exact value Exact value: 2708000 USD 1995-01-01 – 1995-12-31: 2708000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COR THERAPEUTICS INC / DE · 1995-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Capital Expenditure: 2708000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2708000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-98-001234.txt#2836 The citation records this snapshot. The page link may show a newer release later.	−USD 12.85 million Calculation and evidence -10142000 − 2708000 USD Exact free cash flow: -12850000 USD 1995-01-01 – 1995-12-31: -10142000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 2708000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COR THERAPEUTICS INC / DE · 1995-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Free cash flow: -12850000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10142000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-98-001234.txt#2830 Input fundies:CapitalExpenditure: 2708000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-98-001234.txt#2836 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 36.55 million Exact value Exact value: -36546000 USD 1996-01-01 – 1996-12-31: -36546000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COR THERAPEUTICS INC / DE · 1996-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Net Income: -36546000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36546000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000950149-99-000516.txt#2383 The citation records this snapshot. The page link may show a newer release later.	−USD 32.85 million Exact value Exact value: -32850000 USD 1996-01-01 – 1996-12-31: -32850000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COR THERAPEUTICS INC / DE · 1996-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Operating Cash Flow: -32850000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32850000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000950149-99-000516.txt#2401 The citation records this snapshot. The page link may show a newer release later.	USD 2.56 million Exact value Exact value: 2563000 USD 1996-01-01 – 1996-12-31: 2563000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COR THERAPEUTICS INC / DE · 1996-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Capital Expenditure: 2563000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2563000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000950149-99-000516.txt#2407 The citation records this snapshot. The page link may show a newer release later.	−USD 35.41 million Calculation and evidence -32850000 − 2563000 USD Exact free cash flow: -35413000 USD 1996-01-01 – 1996-12-31: -32850000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 2563000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COR THERAPEUTICS INC / DE · 1996-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Free cash flow: -35413000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32850000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000950149-99-000516.txt#2401 Input fundies:CapitalExpenditure: 2563000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000950149-99-000516.txt#2407 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 33.49 million Exact value Exact value: -33492000 USD 1997-01-01 – 1997-12-31: -33492000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COR THERAPEUTICS INC / DE · 1997-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Net Income: -33492000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33492000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-00-001825.txt#2257 The citation records this snapshot. The page link may show a newer release later.	−USD 29.06 million Exact value Exact value: -29062000 USD 1997-01-01 – 1997-12-31: -29062000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COR THERAPEUTICS INC / DE · 1997-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Operating Cash Flow: -29062000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29062000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-00-001825.txt#2276 The citation records this snapshot. The page link may show a newer release later.	USD 1.91 million Exact value Exact value: 1906000 USD 1997-01-01 – 1997-12-31: 1906000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COR THERAPEUTICS INC / DE · 1997-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Capital Expenditure: 1906000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1906000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-00-001825.txt#2282 The citation records this snapshot. The page link may show a newer release later.	−USD 30.97 million Calculation and evidence -29062000 − 1906000 USD Exact free cash flow: -30968000 USD 1997-01-01 – 1997-12-31: -29062000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 1906000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COR THERAPEUTICS INC / DE · 1997-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Free cash flow: -30968000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29062000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-00-001825.txt#2276 Input fundies:CapitalExpenditure: 1906000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0000891618-00-001825.txt#2282 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 27.61 million Exact value Exact value: -27614000 USD 1998-01-01 – 1998-12-31: -27614000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COR THERAPEUTICS INC / DE · 1998-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Net Income: -27614000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27614000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2012 The citation records this snapshot. The page link may show a newer release later.	−USD 7.04 million Exact value Exact value: -7042000 USD 1998-01-01 – 1998-12-31: -7042000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COR THERAPEUTICS INC / DE · 1998-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Operating Cash Flow: -7042000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7042000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030 The citation records this snapshot. The page link may show a newer release later.	USD 3.39 million Exact value Exact value: 3387000 USD 1998-01-01 – 1998-12-31: 3387000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COR THERAPEUTICS INC / DE · 1998-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Capital Expenditure: 3387000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3387000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036 The citation records this snapshot. The page link may show a newer release later.	−USD 10.43 million Calculation and evidence -7042000 − 3387000 USD Exact free cash flow: -10429000 USD 1998-01-01 – 1998-12-31: -7042000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 3387000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COR THERAPEUTICS INC / DE · 1998-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Free cash flow: -10429000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7042000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030 Input fundies:CapitalExpenditure: 3387000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 26.07 million Exact value Exact value: -26070000 USD 1999-01-01 – 1999-12-31: -26070000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COR THERAPEUTICS INC / DE · 1999-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Net Income: -26070000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26070000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2012 The citation records this snapshot. The page link may show a newer release later.	−USD 34.03 million Exact value Exact value: -34031000 USD 1999-01-01 – 1999-12-31: -34031000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COR THERAPEUTICS INC / DE · 1999-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Operating Cash Flow: -34031000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34031000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030 The citation records this snapshot. The page link may show a newer release later.	USD 1.54 million Exact value Exact value: 1538000 USD 1999-01-01 – 1999-12-31: 1538000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COR THERAPEUTICS INC / DE · 1999-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Capital Expenditure: 1538000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1538000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036 The citation records this snapshot. The page link may show a newer release later.	−USD 35.57 million Calculation and evidence -34031000 − 1538000 USD Exact free cash flow: -35569000 USD 1999-01-01 – 1999-12-31: -34031000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1538000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COR THERAPEUTICS INC / DE · 1999-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Free cash flow: -35569000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34031000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030 Input fundies:CapitalExpenditure: 1538000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 16.65 million Exact value Exact value: -16651000 USD 2000-01-01 – 2000-12-31: -16651000 USD Inspect Net Income Open source Share or cite Citation for Net Income · COR THERAPEUTICS INC / DE · 2000-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Net Income: -16651000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16651000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2012 The citation records this snapshot. The page link may show a newer release later.	−USD 20.08 million Exact value Exact value: -20077000 USD 2000-01-01 – 2000-12-31: -20077000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · COR THERAPEUTICS INC / DE · 2000-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Operating Cash Flow: -20077000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20077000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 million Exact value Exact value: 1176000 USD 2000-01-01 – 2000-12-31: 1176000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · COR THERAPEUTICS INC / DE · 2000-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Capital Expenditure: 1176000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1176000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036 The citation records this snapshot. The page link may show a newer release later.	−USD 21.25 million Calculation and evidence -20077000 − 1176000 USD Exact free cash flow: -21253000 USD 2000-01-01 – 2000-12-31: -20077000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 1176000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · COR THERAPEUTICS INC / DE · 2000-12-31 COR THERAPEUTICS INC / DE (edgar:874865) Free cash flow: -21253000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:56:20Z Snapshot: e32af4e0be33fcfe9e69f056eada20bd88e71fad89f817d618efe0ceb7aa9fff Dimensions: Consolidated View: https://fundies.io/companies/edgar/874865?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20077000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2030 Input fundies:CapitalExpenditure: 1176000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/874865/0001012870-01-001199.txt#2036 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000874865, 874865, edgar:874865

COR THERAPEUTICS INC / DE

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1997 1997-01-01 – 1997-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation